...
首页> 外文期刊>European review for medical and pharmacological sciences. >Expression and significance of MiR-126 and VEGF in proliferative diabetic retinopathy
【24h】

Expression and significance of MiR-126 and VEGF in proliferative diabetic retinopathy

机译:MiR-126和VEGF在增生性糖尿病视网膜病变中的表达及意义

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To study the expression and significance of micro ribonucleic acid (miR)-126 and vascular endothelial growth factor (VEGF) in the vitreous body and proliferative membrane tissues of affected eyes and plasma in proliferative diabetic retinopathy (PDR). PATIENTS AND METHODS: A total of 50 PDR patients admitted to our hospital from January 2017 to January 2018 were collected, including 17 cases in stage IV, 20 cases in stage V, and 13 cases in stage VI according to the DR staging criteria. Another 30 patients with an idiopathic macular hole were selected as control group. After admission, the examinations were performed, venous blood was drawn, and vitrectomy was performed, during which the vitreous body and proliferative membrane tissues were taken. The plasma VEGF content was detected via enzyme-linked immunosorbent assay (ELISA). The VEGF protein expression level was detected via Western blotting in vitreous body and proliferative membrane tissues. Moreover, the miR-126 expression was detected via quantitative polymerase chain reaction (qPCR). RESULTS: In the vitreous body tissues, proliferative membrane tissues and plasma, the expression level of miR-126 was significantly lower in control group than that in stage IV, V, and VI groups (p0.05). The miR-126 expression was significantly lower in stage IV group than that in stage V and VI groups (p0.05), meanwhile, miR-126 expression was significantly lower in stage V group than that in stage VI group (p0.05). In the vitreous body tissues, proliferative membrane tissues and plasma, the VEGF mRNA and protein expression levels were significantly higher in control group than those in stage IV, V, and VI groups (p0.05). The VEGF expressions were significantly higher in stage IV group than those in stage V and VI groups (p0.05). In addition, VEGF expressions were significantly higher in stage V group than those in stage VI group (p0.05). Furthermore, the VEGF expression level was negatively correlated with the miR-126 expression level. CONCLUSIONS: We found that the abnormally high expression of miR-126 negatively regulates VEGF, which may be one of the important mechanisms of occurrence of PDR. The miR-126 and VEGF content can serve as important predictors for the condition of PDR.
机译:目的:研究微核糖核酸(miR)-126和血管内皮生长因子(VEGF)在增生性糖尿病视网膜病变(PDR)的患眼和眼玻璃体和增生膜组织中的表达及意义。患者与方法:根据DR分期标准,收集2017年1月至2018年1月入院的50例PDR患者,包括IV期17例,V期20例和VI期13例。另选30例特发性黄斑裂孔患者为对照组。入院后进行检查,抽取静脉血,进行玻璃体切除术,在此期间取出玻璃体和增生性膜组织。通过酶联免疫吸附测定(ELISA)检测血浆VEGF含量。通过Western印迹法检测玻璃体和增生膜组织中的VEGF蛋白表达水平。此外,通过定量聚合酶链反应(qPCR)检测到miR-126表达。结果:在玻璃体组织,增生膜组织和血浆中,对照组miR-126的表达水平明显低于IV,V和VI期组(p <0.05)。 IV期组的miR-126表达明显低于V,VI组(p <0.05),V期组的miR-126表达明显低于VI组(p <0.05) 。在玻璃体组织,增生膜组织和血浆中,对照组的VEGF mRNA和蛋白表达水平明显高于IV,V和VI期组(p <0.05)。 IV期组的VEGF表达明显高于V,VI期组(p <0.05)。此外,V期组的VEGF表达明显高于VI期组(p <0.05)。此外,VEGF表达水平与miR-126表达水平负相关。结论:我们发现miR-126的异常高表达负调控VEGF,这可能是PDR发生的重要机制之一。 miR-126和VEGF含量可以作为PDR病情的重要预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号